ICU supportive care
The daily bundle that prevents harm while the primary problem is treated. SUP only with bleeding risk (coagulopathy, shock, chronic liver disease) → low-dose PPI or H2RA; stop when the risk resolves. Glucose: start insulin at ≥10 mmol/L and target 7.8–11.1, not tighter. VTE: LMWH unless contraindicated. Enteral feeding within 72 h. Restrictive transfusion (Hb 70). New fever: CXR, two sets of blood cultures (plus line cultures if a CVC is in), no routine antipyretics. Platelets 10–50 before a CVC: withholding transfusion was not non-inferior (PACER). Daily: sedation holiday, SBT, mobilise, review lines and drugs.
ICU daily checklist
- analgesia first, light sedation (RASS −2 to +1), CAM-ICU each shift
- SAT + SBT daily if ventilated >24 h
- enteral nutrition started within 72 h unless contraindicated
- SUP (PPI or H2RA, low dose) only if coagulopathy, shock or chronic liver disease; stop when risk resolves
- glucose ≥10 mmol/L → insulin protocol; target 7.8–11.1 mmol/L
- LMWH prophylaxis unless bleeding or platelets too low; mechanical if contraindicated
- restrictive transfusion: Hb trigger 70 g/L
- mobilise: daily rehabilitation goal
- lines, urinary catheter, drains: still needed? Remove if not
- medication review: stop home drugs that don’t fit, renally adjust, de-escalate antibiotics
- goals of care and family update
stress ulcer prophylaxis
Shock and coagulopathy → mucosal hypoperfusion → stress ulceration. Clinically important bleeding is now uncommon, so prophylaxis helps only those at risk.
- at risk (conditional): coagulopathy, shock, chronic liver disease. Also neurocritical care patients (very low certainty). Mechanical ventilation alone wasn’t on the guideline list, but REVISE enrolled ventilated patients
- enteral nutrition itself reduces bleeding (conditional, moderate). But fed patients with a risk factor still get SUP; fed patients without one don’t
- PPI or H2RA: either first line per SCCM-ASHP; SSC 2026 prefers a PPI (H2RA if unavailable). Low dose (e.g. pantoprazole 40 mg daily), enteral or IV
- REVISE (2024): IV pantoprazole in ventilated adults reduced clinically important upper GI bleeding (~1% vs ~3.5%) with no difference in 90-day mortality or pneumonia
- harms (C. difficile, pneumonia) haven’t been confirmed in RCTs, but the drug often goes home with the patient. Stop at ICU discharge or when the risk resolves → proton pump inhibitors
glycaemic control
- treat persistent glucose ≥10 mmol/L (SCCM good practice; SSC 2026 strong); use protocols with a low hypoglycaemia risk and treat hypoglycaemia at once
- target 7.8–11.1 mmol/L, not 4.4–7.7 (conditional, moderate): tight control (NICE-SUGAR era) increases hypoglycaemia without improving survival
- continuous IV insulin over intermittent SC when starting (conditional, very low certainty), using a protocol with explicit decision support; checks ≤1 h while unstable
- chronic hyperglycaemia (high HbA1c): a target nearer the patient’s usual glucose may be better, but that’s observational only
DKA and HHS have their own protocols → diabetic ketoacidosis — management.
new fever in the ICU
- measure: intravascular, bladder or oesophageal probe if present; otherwise oral or rectal. Not axillary, tympanic or temporal
- always: CXR; ≥2 blood culture sets (ideally 60 mL total) from different sites at the same time. With a CVC, take paired central + peripheral cultures (differential time to positivity), sampling ≥2 lumens
- directed: urine only if pyuria and suspected UTI (replace the catheter, culture the new one); thoracic ultrasound if CXR abnormal; viral NAAT if respiratory symptoms; formal abdominal ultrasound if abdominal signs or abnormal LFTs; CT after recent thoracic, abdominal or pelvic surgery
- unexplained after that → FDG-PET/CT if safe to transport (weak)
- think non-infectious: drugs, VTE, transfusion, pancreatitis, acalculous cholecystitis, adrenal insufficiency, alcohol withdrawal, CNS injury
- antipyretics: not routinely to lower temperature (weak, moderate); fine for comfort
other daily items
| item | approach |
|---|---|
| VTE prophylaxis | pharmacological, LMWH over UFH (strong, SSC 2026); mechanical only if bleeding or contraindication → deep vein thrombosis |
| nutrition | enteral within 72 h (SSC 2026) |
| transfusion | restrictive, Hb 70 g/L (strong in sepsis); higher in active ACS → anaemia |
| platelets before CVC | see below |
| mobility | enhanced mobilisation/rehabilitation (PADIS 2025, conditional, moderate) → [[extubation and liberation from mechanical ventilation |
| sedation, delirium, sleep | → sedation in the ICU |
| probiotics | not recommended (SSC 2026) |
platelets before central line placement
- PACER (2023) (platelets 10–50 × 10⁹/L, ICU and haematology, ultrasound-guided): withholding one prophylactic platelet unit was not non-inferior. Catheter-related bleeding grade 2–4 was 11.9% without transfusion vs 4.8% with it, mostly minor bleeding but some grade 3
- practical: platelets 10–50 → transfuse one unit before, or accept the risk with ultrasound guidance at a compressible site after discussion. Above 50 → no transfusion → thrombocytopaenia
Prepared 2026-10-29. Not yet verified — check every number against the sources.